 <h1>Lymphocyte immune globulin, anti-thy (equine) Side Effects</h1><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li></ul><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to lymphocyte immune globulin, anti-thy (equine): parenteral concentrate for injection</i></p><h3>Warning</h3><p><ul>
<li>
Should be used only by clinicians experienced in immunosuppressive therapy for the management of renal transplant or aplastic anemia patients.&lt;sup&gt;b&lt;/sup&gt;</li></ul></p><ul>
<li>
Should be used only by clinicians experienced in immunosuppressive therapy for the management of renal transplant or aplastic anemia patients.&lt;sup&gt;b&lt;/sup&gt;</li></ul><p>
<li>
Patients receiving antithymocyte globulin (equine) should be treated in facilities equipped and staffed with adequate laboratory and supportive medical resources.&lt;sup&gt;b&lt;/sup&gt;</li></p><p></p><p>Side effects include:</p><p>Renal allotransplantation: Fever, chills, leukopenia, thrombocytopenia, dermatologic reactions (rash, pruritus, urticaria, wheal and flare).       </p><p>Aplastic anemia: Fever, chills, skin reactions, arthralgia, headache, myalgia, nausea, chest pain, phlebitis, serum sickness.    </p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to lymphocyte immune globulin, anti-thy (equine): intravenous solution</i></p><h3>Hypersensitivity</h3><p><b>Uncommon</b> (0.1% to 1%): Anaphylactic reaction<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Very common</b> (10% or more): Rash (26%)</p><p><b>Common</b> (1% to 10%): Urticaria, pruritus, vomiting, diarrhea, abdominal pain upper</p><p><b>Uncommon</b> (0.1% to 1%): Herpes simplex, allergic dermatitis, toxic epidermal necrolysis (TEN)</p><p><b>Postmarketing reports</b>: Hyperhidrosis<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Very common</b> (10% or more): Arthralgia (17%)</p><p><b>Common</b> (1% to 10%): Chest pain, back pain<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Common</b> (1% to 10%): Nausea</p><p><b>Uncommon</b> (0.1% to 1%): Stomatitis</p><p><b>Postmarketing reports</b>: Abdominal pain, GI hemorrhage, GI perforation, oral pain<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Common</b> (1% to 10%): Thrombophlebitis, hypertension, hypotension, bradycardia, arteriovenous fistula thrombosis, tachycardia, iliac vein occlusion</p><p><b>Postmarketing reports</b>: Congestive heart failure, deep vein thrombosis, vasculitis<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Very common</b> (10% or more): Thrombocytopenia (22%), leukopenia (18%)</p><p><b>Postmarketing reports</b>: Anemia, eosinophilia, granulocytopenia, hemolysis, hemolytic anemia, neutropenia, pancytopenia<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Common</b> (1% to 10%): Dyspnea</p><p><b>Uncommon</b> (0.1% to 1%): Pleural effusion, hiccups, laryngospasm, pulmonary edema</p><p><b>Postmarketing reports</b>: Apnea, cough, epistaxis, oropharyngeal pain<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Common</b> (1% to 10%): Headache, dizziness</p><p><b>Uncommon</b> (0.1% to 1%): Convulsion, encephalitis, paresthesia</p><p><b>Postmarketing reports</b>: Dyskinesia, Syncope, tremor<sup>[Ref]</sup></p><h3>Local</h3><p><b>Common</b> (1% to 10%): Infusion site pain</p><p><b>Postmarketing reports</b>: Infusion site erythema, infusion site swelling<sup>[Ref]</sup></p><h3>Renal</h3><p><b>Uncommon</b> (0.1% to 1%): Renal function test abnormal, renal artery thrombosis</p><p><b>Postmarketing reports</b>: Kidney rupture, renal failure acute<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Uncommon</b> (0.1% to 1%): Periorbital edema<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Uncommon</b> (0.1% to 1%): Night sweats, hyperglycemia, proteinuria</p><p><b>Postmarketing reports</b>: Flank pain, muscle rigidity, myalgia, pain in extremity<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Common</b> (1% to 10%): Liver function test abnormal<sup>[Ref]</sup></p><h3>Immunologic</h3><p><b>Common</b> (1% to 10%): Infection</p><p><b>Uncommon</b> (0.1% to 1%): Serum sickness</p><p><b>Postmarketing reports</b>: Hepatitis viral, localized infection, systemic infection<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Uncommon</b> (0.1% to 1%): Agitation</p><p><b>Postmarketing reports</b>: Confusion, disorientation<sup>[Ref]</sup></p><h3>Other</h3><p><b>Very common</b> (10% or more): Pyrexia (40%), chills (27%)</p><p><b>Common</b> (1% to 10%): Edema, lymphadenopathy, asthenia, malaise, wound dehiscence</p><p><b>Postmarketing reports</b>: Aplasia, pain<sup>[Ref]</sup></p><p id="ref_1">1. "Product Information. Atgam (lymphocyte immune globulin, anti-thy (equine))." Pfizer U.S. Pharmaceuticals Group, New York, NY. </p><h2>More about lymphocyte immune globulin, anti-thy (equine)</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>En Espa√±ol</li>
<li>Drug class: selective immunosuppressants</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Aplastic Anemia</li>
<li>Renal Transplant</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>